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sCPII and sPIIANP only appeared to be correlated (R = 0.29;
p = 0.002). Between synthesis and degradation markers, only
sCPII and uCTX-II appeared to be weakly correlated (R = 0.18;
p = 0.016). The ratio of uCTX-II or uTIINE to sCPII enhanced the
differences between OA patients and control subjects.
Conclusions: In the present study, the combination of both syn-
thesis and degradation markers of type II collagen appeared to
better differentiate OA patients from healthy volunteers. However,
each of these markers may reflect the activity of different set of
enzymes that may play a critical role at different stages of the
disease, and therefore evaluation of the full panel of biomarkers
may be required to understand disease progression and potential
therapies.
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Purpose: In classic collagen-induced arthritis (CIA) models, the
disease is induced by injection of type II collagen. Such murine
CIA models are widely used to study the pathology of rheumatoid
arthritis (RA) and to evaluate the effects of potential anti-arthitic
drugs. Recently, a rapid murine model of RA employing mono-
clonal antibodies against type II collagen was developed which
reduces the timeline compared to classic CIA experiments.
The objective of the present study was to characterize the clinical,
biochemical, 3-D microstructural and histopathological features
in BALB/c mice injected with anti-type II collagen antibodies.
Methods: 48 eight-week-old mice were randomly assigned to
6 groups with 8 mice in each group: One control group (non-
diseased), four CIA groups and one CIA + dexamethasone
(Dex) group. CIA was induced by intravenous injection of 2 or 4
mg/mouse Arthrogen-CIA® anti-type II collagen antibodies (mAB)
on day 1 followed by 25 or 50 μg/mouse lipopolysaccharide (LPS)
on day 3. Additionally, the treated group induced with 2 mg mAB
and 50 μg LPS received daily doses of Dex (0.5 mg/kg) by
gavage following onset of the disease (day 5) until termination of
the experiment (day 15).
Paw inflammation (redness and swelling) were evaluated daily
for all animals.
Circulating levels of matrix metalloproteinase-derived fragments
of collagen type II were measured at study termination by serum
CTX-II. Structural changes were evaluated by histopathology and
micro-CT scanning of the hindpaws.
Results: On the 5th day after induction of disease all CIA mice
had significantly higher paw inflammation scores than the control
group (p<0.05). Hereafter the treated group received daily doses
of Dex, and at study termination the paw inflammation score for
this group had decreased to the level of the control group and
was significantly different from the CIA group (p<0.05).
The levels of MMP-derived collagen type II fragments in serum at
study termination were found to correlate to the paw inflammation
scores (p<0.001). As shown in Figure 1, the serum levels of
collagen type II fragments for the CIA group induced by 2
mg mAB and 50 μg LPS (B) were significantly increased at
termination compared to the non-diseased control group (A)
(p=0.027). Daily doses of Dex were able to suppress the level of
these fragments in the treated group (C) compared to the CIA
group (B) (p<0.0001).
Histopathology demonstrated a noticeable reduction in inflamma-
tion, cartilage damage, bone resorption and osteophyte formation
in the group treated with Dex compared to the CIA groups.
Micro-CT analyses of the hindpaws showed a marked increase
in the extent of new bone formation and a slight increase in
bone resorption in the CIA groups compared to the non-diseased
control group and demonstrated the complete prevention of these
changes in the treated group.
Fig. 1. Levels of MMP-derived fragments of collagen type II in serum at study
termination. A) Non-diseased control group. B) CIA group. C) CIA + dexametha-
sone group.
Conclusions: Intravenous injection of 2 mg mAB followed by
50 μg of LPS induced a persistent disease in the BALB/c mice
with an incidence of 100%. Moreover, treatment with 0.5 mg/kg
dexamethasone relieved the mice from all of the assessed dis-
ease parameters. The anti-inflammatory action of dexametha-
sone was reflected in a dramatic decrease in serum levels of
matrix metalloproteinase-derived fragments of collagen type II.
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Purpose: The Osteoarthritis Initiative (OAI) is targeted at iden-
tifying biomarkers for development and progression of symp-
tomatic knee OA. Magnetic resonance (MR) imaging can pro-
vide three-dimensional metrics of cartilage morphology, with fast
low angle shot (FLASH) and double echo steady state (DESS)
sequences with water excitation having been validated in this
context at 3 Tesla. The purpose of this pilot is to compare the
sensitivity of the two sequences to detect change in cartilage
volume over 2 years.
Methods: 9 participants with mild to moderate OA were exam-
ined twice at baseline (BL), twice at 1 year (Y1), and once at
2 years (Y2). A double oblique coronal FLASH with 1.5 mm
slice thickness and a sagittal DESS with 0.7 mm slice thickness
were acquired. Coronal multiplanar reformats (MPR) from the
DESS were obtained at 1.5 mm slice thickness. Femorotibial
joint cartilage plates (medial and lateral tibia = MT/LT, central
medial/lateral central femoral condyles = cMF/cLF) were exam-
ined using FLASH, DESS and MPR, and the patella (P) and
posterior medial and lateral femoral condyles (pMF/pLF) with
the sagittal DESS. Proprietary software (Chondrometrics GmbH,
Ainring, Germany) was used for image analysis. Knees were
analyzed in quadruples (Y1) and pairs (Y2) with blinding to the
order of acquisition. In the femorotibial compartment, aggregate
